Results We summarize consensus recommendations from a global working group, organized into seven thematic modules, to guide alignment of GLP-1 therapies with dietary and lifestyle interventions across the key stages of the weight management journey
For 2026, OptumRx is maintaining Zepbound on formularies for plans that cover obesity medications
PubMed Fuku, N., Pareja-Galeano, H., Zempo, H., Alis, R., Arai, Y., Lucia, A., & Hirose, N
Would you like to see sample protein targets or a short resistance plan that fits into a busy week?
Srivastava, S., Mennemeier, M., & Pimple, S
Unlike single-target medications that activate only one receptor pathway, this investigational compound simultaneously engages three distinct metabolic receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon